The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...

DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

Feb 25 (Reuters) - The U.S. Food and Drug Administration approved on Wednesday Eton Pharmaceuticals' oral liquid therapy for a rare childhood hormonal disorder, giving families an easier way to manage ...

Diabetes insipidus is a rare condition that leads to excessive urination. This can lead to severe dehydration and high sodium levels — and these can mean serious complications. Share on Pinterest ...

Treatment of postoperative diabetes insipidus should be individualized ( Box 1). Optimally, patients should be monitored for the development of polyuria or hypo-osmolality. Fluid intake and output ...

Diabetes Insipidus is a rare condition that affects the body’s ability to regulate fluid balance. Unlike the more well-known diabetes mellitus, which involves problems with blood sugar regulation, ...

Diabetes insipidus is caused by a decrease in the level or function of antidiuretic hormone (ADH), also known of as vasopressin. ADH helps regulate the amount of fluid in the body and it is ...

Please provide your email address to receive an email when new articles are posted on . A group of representatives from national and international endocrine, nephrology and pediatric societies has ...

Transient diabetes insipidus almost always begins within 24-48 h of surgery, and usually abates within several days. Both transient diabetes insipidus and the first phase of the triphasic pattern are ...

Diabetes insipidus (DI) is a condition that arises either due to the body’s inability to produce sufficient quantities of the hormone known as antidiuretic hormone (ADH) or the body’s inability to ...

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.